Carmen Mir Maresma, MD, PhD, FEBU, Fundacion Instituto Valenciano Oncologia, Valencia, Spain, discusses whether prostate-sparing radical cystectomy is a safe option for muscle invasive bladder cancer (MIBC). Dr Maresma concludes that, despite a lack in data, there remains a role for prostate-sparing radical cystectomy, particularly for those who want to keep sexual function and accept an increased risk of recurrence. Whether reproductive organ-sparing radical cystectomy is safe in women with MIBC is also discussed. This interview took place at the EAU congress in Milan, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.